Recent Updates
Recently added Catalysts
UHS

Steve Filton Chief Financial Officer

Key Takeaway: CONTACT: Steve Filton Chief Financial Officer July 26, 2016 610-768-3300 UNIVERSAL HEALTH SERVICES, INC. REPORTS 2016 SECOND QUARTER FINANCIAL RESULTS Consolidated Results of Operations, As Reported and As Adjusted Three-month periods ended June 30, 2016 and 2015: K

Full Press Release Details

CONTACT: Steve Filton
Chief Financial Officer July 26, 2016
610-768-3300
UNIVERSAL HEALTH SERVICES, INC. REPORTS
2016 SECOND QUARTER FINANCIAL RESULTS
Consolidated Results of Operations, As Reported and As Adjusted Three-month periods ended June 30, 2016 and 2015:
KING OF PRUSSIA, PA Universal Health Services, Inc. (NYSE: UHS) announced today that its reported net income attributable to UHS was
$185.6 million, or $1.89 per diluted share, during the second quarter of 2016 as compared to $182.2 million, or $1.80 per diluted share, during the comparable quarter of 2015. Net revenues increased 6.8% to $2.43 billion during the second quarter of
2016 as compared to $2.28 billion during the second quarter of 2015.
For the three-month period ended June 30, 2016, our adjusted
net income attributable to UHS per diluted share, as calculated on the attached Schedule of Non-GAAP Supplemental Consolidated Statements of Income Information ( Supplemental Schedule ), increased to $1.94 per diluted share, as compared to
$1.85 per diluted share during the second quarter of 2015. As reflected on the Supplemental Schedule, included in our reported results during each of the second quarters of 2016 and 2015, are net unfavorable after-tax impacts of $.05 per diluted
share related to the incentive income and depreciation and amortization expense recorded in connection with the implementation of electronic health records ( EHR ) applications at our acute care hospitals.
Consolidated Results of Operations, As Reported and As Adjusted Six-month periods ended June 30, 2016 and 2015:
Reported net income attributable to UHS was $376.3 million, or $3.81 per diluted share, during the first six months of 2016 as compared to
$356.5 million, or $3.54 per diluted share, during the comparable period of 2015. Net revenues increased 8.4% to $4.88 billion during the first six months of 2016 as compared to $4.50 billion during the comparable period of 2015.
For the six-month period ended June 30, 2016, our adjusted net income attributable to UHS per diluted share, as calculated on the
Supplemental Schedule, increased to $3.92 per diluted share, as compared to $3.63 per diluted share during the comparable period of 2015. As reflected on the Supplemental Schedule, included in our reported results during the six-month periods ended
June 30, 2016 and 2015, are net unfavorable after-tax impacts of $.11 per diluted share and $.09 per diluted share, respectively, related to the incentive income and depreciation and amortization expense recorded in connection with the
implementation of EHR applications at our acute care hospitals.
Acute Care Services Three and six-month periods ended June 30, 2016 and
During the second quarter of 2016, at our acute care hospitals owned during both periods ( same facility basis ),
adjusted admissions (adjusted for outpatient activity) increased 3.9% and adjusted patient days increased 2.8%, as compared to the second quarter of 2015. Net revenues from our acute care services increased 7.4% during the second quarter of 2016 as
compared to the second quarter of the prior year. At these facilities, net revenue per adjusted admission increased 1.3% while net revenue per adjusted patient day increased 2.4% during the second quarter of 2016 as compared to the comparable
quarter of 2015. On a same facility basis, the operating margin generated from our acute care services was 17.7% during the second quarter of 2016 as compared to 19.1% during the second quarter of 2015. We define operating margin as net revenues
less salaries, wages and benefits, other operating expenses and supplies expense, divided by net revenues (excluding the impact of EHR and other items, if applicable, as indicated on the Supplemental Schedules).
During the first six months of 2016, at our acute care hospitals on a same facility basis,
adjusted admissions increased 5.8% and adjusted patient days increased 3.1%, as compared to the first six months of 2015. Net revenues from our acute care services increased 9.7% during the first six months of 2016 as compared to the comparable
period of the prior year. At these facilities, net revenue per adjusted admission increased 2.2% while net revenue per adjusted patient day increased 4.8% during the first six months of 2016 as compared to the comparable period of 2015. On a same
facility basis, the operating margin generated from our acute care services was 19.4% during the first six months of 2016 as compared to 19.8% during the comparable period of 2015.
We provide care to patients who meet certain financial or economic criteria without charge or at amounts substantially less than our
established rates. Because we do not pursue collection of amounts determined to qualify as charity care, they are not reported in net revenues or in accounts receivable, net. Our acute care hospitals provided charity care and uninsured discounts,
based on gross charges, amounting to approximately $339 million and $263 million during the three-month periods ended June 30, 2016 and 2015, respectively, and approximately $684 million and $550 million during the six-month periods ended
June 30, 2016 and 2015, respectively. The provision for doubtful accounts at our acute care hospitals amounted to approximately $179 million and $149 million during the three-month periods ended June 30, 2016 and 2015, respectively, and
approximately $319 million and $274 million during the six-month periods ended June 30, 2016 and 2015, respectively. Our acute care hospitals experienced an increase in the aggregate of charity care, uninsured discounts and provision for
doubtful accounts, as a percentage of gross charges, during the three and six-month period ended June 30, 2016, as compared to the comparable periods of 2015.
Behavioral Health Care Services Three and six-month periods ended June 30, 2016 and 2015:
During the second quarter of 2016, at our behavioral health care facilities on a same facility basis, adjusted admissions decreased 0.3% while
adjusted patient days increased 0.2% as compared to the second quarter of 2015. At these facilities, net revenue per adjusted admission increased 2.4% while net revenue per adjusted patient day increased 1.9% during the second quarter of 2016 as
compared to the comparable quarter in 2015. On a same facility basis, our behavioral health services net revenues increased 2.0% during the second quarter of 2016, as compared to the second quarter of 2015, and the operating margins were 28.1%
and 28.7% during the second quarters of 2016 and 2015, respectively.
During the first six months of 2016, at our behavioral health care
facilities on a same facility basis, adjusted admissions increased 0.5% while adjusted patient days increased 0.7% as compared to the comparable period of 2015. At these facilities, net revenue per adjusted admission increased 2.1% while net revenue
per adjusted patient day increased 1.9% during the first six months of 2016 as compared to the comparable period in 2015. On a same facility basis, our behavioral health services net revenues increased 2.7% during the first six months of 2016,
as compared to the comparable period of 2015, and the operating margins were 28.0% and 28.6% during the first six months of 2016 and 2015, respectively.
Share Repurchase Program:
In February of 2016, our Board of Directors authorized a $400 million increase to our stock repurchase program, which increased the aggregate authorization to
$800 million from the previous $400 million authorization approved during the third quarter of 2014. Pursuant to this program, we may purchase shares of our Class B Common Stock, from time to time as conditions allow, on the open market or in
negotiated private transactions.
In conjunction with this program, during the second quarter of 2016, we repurchased 235,352 shares at an
aggregate cost of $29.1 million (approximately $123 per share). During the first six months of 2016, we repurchased approximately 1.6 million shares at an aggregate cost of $181.5 million (approximately $115 per share). Since inception of the
program through June 30, 2016, we repurchased approximately 3.5 million shares at an aggregate cost of approximately $405.7 million (approximately $117 per share).
Conference call information:
will hold a conference call for investors and analysts at 9:00 a.m. eastern time on July 27, 2016. The dial-in number is 1-877-648-7971.
A live broadcast of the conference call will be available on our website at www.uhsinc.com. A replay of the call will be available following
the conclusion of the live call and will be available for one full year.
General Information, Forward-Looking Statements and Risk Factors and
Non-GAAP Financial Measures:
Universal Health Services, Inc. ( UHS ) is one of the nation s largest hospital
companies operating through its subsidiaries acute care hospitals, behavioral health facilities and ambulatory centers located throughout the United States, the United Kingdom, Puerto Rico and the U.S. Virgin Islands. It acts as the advisor to
Universal Health Realty Income Trust, a real estate investment trust (NYSE:UHT). For additional information on the Company, visit our web site: http://www.uhsinc.com.
This press release contains forward-looking statements based on current management expectations. Numerous factors, including those disclosed
herein, those related to healthcare industry trends and those detailed in our filings with the Securities and Exchange Commission (as set forth in Item 1A-Risk Factors and in Item 7-Forward-Looking Statements and Risk
Factors in our Form 10-K for the year ended December 31, 2015 and in Item 2-Forward Looking Statements and Risk Factors in our Form 10-Q for the quarterly period ended March 31, 2016), may cause the results to differ
materially from those anticipated in the forward-looking statements. Many of the factors that will determine our future results are beyond our capability to control or predict. These statements are subject to risks and uncertainties and therefore
actual results may differ materially. Readers should not place undue reliance on such forward-looking statements which reflect management s view only as of the date hereof. We undertake no obligation to revise or update any forward-looking
statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
We believe that operating income, operating margin, adjusted net income attributable to UHS,
adjusted net income attributable to UHS per diluted share and earnings before interest, taxes, depreciation and amortization ( EBITDA ), which are non-GAAP financial measures ( GAAP is Generally Accepted Accounting Principles in
the United States of America), are helpful to our investors as measures of our operating performance. In addition, we believe that, when applicable, comparing and discussing our financial results based on these measures, as calculated, is helpful to
our investors since it neutralizes the effect in each year of material items related to the implementation of EHR applications at our acute care hospitals and other items that are nonrecurring or non-operational in nature including, but not limited
to, costs related to extinguishment of debt, gains on sales of assets and businesses, reserves for settlements, legal judgments and lawsuits, impairments of long-lived assets and other amounts that may be reflected in the current or prior year
financial statements that relate to prior periods. To obtain a complete understanding of our financial performance these measures should be examined in connection with net income, determined in accordance with GAAP, as presented in the condensed
consolidated financial statements and notes thereto in this report or in our other filings with the Securities and Exchange Commission including our Report on Form 10-K for the year ended December 31, 2015 and our Report on Form 10-Q for the
quarterly period ended March 31, 2016. Since the items included or excluded from these measures are significant components in understanding and assessing financial performance under GAAP, these measures should not be considered to be
alternatives to net income as a measure of our operating performance or profitability. Since these measures, as presented, are not determined in accordance with GAAP and are thus susceptible to varying calculations, they may not be comparable to
other similarly titled measures of other companies. Investors are encouraged to use GAAP measures when evaluating our financial performance.
Our acute care hospitals are eligible for Medicare and Medicaid EHR incentive payments upon implementation of the EHR application, once they
have demonstrated meaningful use of certified EHR technology for the applicable stage or have completed attestations to their adoption or implementation of certified EHR technology. However, there may be timing differences in the recognition of the
incentive income and expenses recorded in connection with the implementation of the EHR application which may cause material period-to-period changes in our future results of operations. Pursuant to regulations, hospitals that did not qualify as a
meaningful user of EHR by 2015 are subject to a reduced market basket update to the inpatient prospective payment system standardized amount in 2015 and each subsequent fiscal year. We believe that all of our acute care hospitals have met the
applicable meaningful use criteria and therefore are not subject to a reduced market basked update to the inpatient prospective payment standardized amount. Under the HITECH Act, hospitals must continue to meet the applicable meaningful use criteria
in each fiscal year or they will be subject to a market basket update reduction in a subsequent fiscal year.
Universal Health Services, Inc.
Consolidated Statements of Income
(in thousands, except per share amounts)
Three months ended June 30, Six months ended June 30,
2016 2015 2016 2015
Net revenues before provision for doubtful accounts $ 2,638,848 $ 2,452,680 $ 5,258,441 $ 4,832,781
Less: Provision for doubtful accounts 207,993 177,476 377,788 332,224
Net revenues 2,430,855 2,275,204 4,880,653 4,500,557
Operating charges:
Salaries, wages and benefits 1,130,933 1,044,064 2,279,072 2,075,767
Other operating expenses 585,995 535,711 1,147,579 1,041,677
Supplies expense 254,422 240,979 509,672 479,720
Depreciation and amortization 101,411 97,257 205,460 196,255
Lease and rental expense 24,806 23,196 49,258 46,087
Electronic health records incentive income 0 (1,395 ) 0 (1,395 )
2,097,567 1,939,812 4,191,041 3,838,111
Income from operations 333,288 335,392 689,612 662,446
Interest expense, net 30,442 27,684 60,042 57,721
Income before income taxes 302,846 307,708 629,570 604,725
Provision for income taxes 107,397 106,304 218,402 208,998
Net income 195,449 201,404 411,168 395,727
Less: Income attributable to noncontrolling interests 9,872 19,211 34,832 39,235
Net income attributable to UHS $ 185,577 $ 182,193 $ 376,336 $ 356,492
Basic earnings per share attributable to UHS (a) $ 1.91 $ 1.84 $ 3.86 $ 3.60
Diluted earnings per share attributable to UHS (a) $ 1.89 $ 1.80 $ 3.81 $ 3.54
Universal Health Services, Inc.
Footnotes to Consolidated Statements of Income
(in thousands, except per share amounts)
Three months ended June 30, Six months ended June 30,
2016 2015 2016 2015
(a) Earnings per share calculation:
Basic and diluted:
Net income attributable to UHS $ 185,577 $ 182,193 $ 376,336 $ 356,492
Less: Net income attributable to unvested restricted share grants (84 ) (71 ) (173 ) (139 )
Net income attributable to UHS basic and diluted $ 185,493 $ 182,122 $ 376,163 $ 356,353
Weighted average number of common shares basic 97,109 99,004 97,358 98,957
Basic earnings per share attributable to UHS: $ 1.91 $ 1.84 $ 3.86 $ 3.60
Weighted average number of common shares 97,109 99,004 97,358 98,957
Add: Other share equivalents 1,280 1,923 1,284 1,830
Weighted average number of common shares and equiv. diluted 98,389 100,927 98,642 100,787
Diluted earnings per share attributable to UHS: $ 1.89 $ 1.80 $ 3.81 $ 3.54
Universal Health Services, Inc.
Schedule of Non-GAAP Supplemental Consolidated Statements of Income Information ( Supplemental Schedule )
For the three months ended June 30, 2016 and 2015
(in thousands, except per share amounts)
Three months ended June 30, 2016 Three months ended June 30, 2015
Net revenues before provision for doubtful accounts $ 2,638,848 $ 2,452,680
Less: Provision for doubtful accounts 207,993 177,476
Net revenues 2,430,855 100.0 % 2,275,204 100.0 %
Operating charges:
Salaries, wages and benefits 1,130,933 46.5 % 1,044,064 45.9 %
Other operating expenses 585,995 24.1 % 535,711 23.5 %
Supplies expense 254,422 10.5 % 240,979 10.6 %
EHR incentive income 0 0.0 % (1,395 ) -0.1 %
1,971,350 81.1 % 1,819,359 80.0 %
Operating income/margin ( EBITDAR ) 459,505 18.9 % 455,845 20.0 %
Lease and rental expense 24,806 23,196
Income attributable to noncontrolling interests 9,872 19,211
Earnings before depreciation and amortization, interest expense, and income taxes ( EBITDA ) 424,827 17.5 % 413,438 18.2 %
Depreciation and amortization 101,411 97,257
Interest expense, net 30,442 27,684
Income before income taxes 292,974 288,497
Provision for income taxes 107,397 106,304
Net income attributable to UHS $ 185,577 $ 182,193
Calculation of Adjusted Net Income Attributable to UHS
Three months ended June 30, 2016 Three months ended June 30, 2015
Amount Per Diluted Share Amount Per Diluted Share
Calculation of Adjusted Net Income Attributable to UHS
Net income attributable to UHS $ 185,577 $ 1.89 $ 182,193 $ 1.80
Plus/minus impact of EHR implementation:
EHR-related incentive income, pre-tax (1,395 )
EHR-related depreciation & amortization, pre-tax 9,187 9,306
EHR-related minority interest in earnings of consolidated entities, pre-tax (455 ) (963 )
Income tax provision on EHR-related items (3,255 ) (2,590 )
After-tax impact of EHR-related items 5,477 0.05 4,358 0.05
Adjusted net income attributable to UHS $ 191,054 $ 1.94 $ 186,551 $ 1.85
Universal Health Services, Inc.
Schedule of Non-GAAP Supplemental Consolidated Statements of Income Information ( Supplemental Schedule )
For the six months ended June 30, 2016 and 2015
(in thousands, except per share amounts)
Last updated: Jul 26, 2016